148 related articles for article (PubMed ID: 21030861)
21. [Clinicopathological features of pancreatic neuroendocrine neoplasms: a retrospective analysis of 64 cases].
Yao W; Wang W; Li G
Zhonghua Zhong Liu Za Zhi; 2014 Apr; 36(4):287-93. PubMed ID: 24989916
[TBL] [Abstract][Full Text] [Related]
22. Neuroendocrine Differentiation in Thymic Carcinomas: A Diagnostic Pitfall: An Immunohistochemical Analysis of 27 Cases.
Weissferdt A; Moran CA
Am J Clin Pathol; 2016 Mar; 145(3):393-400. PubMed ID: 27124922
[TBL] [Abstract][Full Text] [Related]
23. Pax8 as a useful adjunct marker to differentiate pancreatic serous cystadenoma from clear cell renal cell carcinoma in both cytologic and surgical specimens.
Chi Z; Xu J; Karamchandani DM; Peng L
Diagn Pathol; 2023 Apr; 18(1):54. PubMed ID: 37098593
[TBL] [Abstract][Full Text] [Related]
24. The clinical relevance of chromogranin A as a biomarker for gastroenteropancreatic neuroendocrine tumors.
Lawrence B; Gustafsson BI; Kidd M; Pavel M; Svejda B; Modlin IM
Endocrinol Metab Clin North Am; 2011 Mar; 40(1):111-34, viii. PubMed ID: 21349414
[TBL] [Abstract][Full Text] [Related]
25. Basics for surgeons about the immunohistochemistry role in pancreatic NETs diagnosis.
Romano L; Giuliani A; Vicentini V; Schietroma M; Carlei F
Eur Rev Med Pharmacol Sci; 2021 Mar; 25(6):2548-2553. PubMed ID: 33829441
[TBL] [Abstract][Full Text] [Related]
26. A case of endocrine carcinoma of the rectum.
Oshiro T; Yamamoto S
Jpn J Clin Oncol; 2011 May; 41(5):730. PubMed ID: 21536694
[No Abstract] [Full Text] [Related]
27. [Gastrointestinal and pancreatic neuroendocrine tumors: a clinicopathologic and immunohistochemical study].
Sun LM; Qiu XS; Wang EH
Zhonghua Bing Li Xue Za Zhi; 2012 Oct; 41(10):696-7. PubMed ID: 23302313
[No Abstract] [Full Text] [Related]
28. Pancreatic neuroendocrine tumor and solid-pseudopapillary neoplasm: Key immunohistochemical profiles for differential diagnosis.
Ohara Y; Oda T; Hashimoto S; Akashi Y; Miyamoto R; Enomoto T; Satomi K; Morishita Y; Ohkohchi N
World J Gastroenterol; 2016 Oct; 22(38):8596-8604. PubMed ID: 27784972
[TBL] [Abstract][Full Text] [Related]
29. ABCD1 as a Novel Diagnostic Marker for Solid Pseudopapillary Neoplasm of the Pancreas.
Liu YA; Liu Y; Tu J; Shi Y; Pang J; Huang Q; Wang X; Lin Z; Zhao Y; Wang W; Peng J; Wu W
Am J Surg Pathol; 2024 May; 48(5):511-520. PubMed ID: 38567813
[TBL] [Abstract][Full Text] [Related]
30. INSM1 Demonstrates Superior Performance to the Individual and Combined Use of Synaptophysin, Chromogranin and CD56 for Diagnosing Neuroendocrine Tumors of the Thoracic Cavity.
Rooper LM; Sharma R; Li QK; Illei PB; Westra WH
Am J Surg Pathol; 2017 Nov; 41(11):1561-1569. PubMed ID: 28719469
[TBL] [Abstract][Full Text] [Related]
31. Serous cystadenoma of the pancreas: clinical and pathological features in 33 patients.
Colonna J; Plaza JA; Frankel WL; Yearsley M; Bloomston M; Marsh WL
Pancreatology; 2008; 8(2):135-41. PubMed ID: 18382099
[TBL] [Abstract][Full Text] [Related]
32. CD56 expression of neuroendocrine neoplasms on immunophenotyping by flow cytometry: a novel diagnostic approach to fine-needle aspiration biopsy.
Farinola MA; Weir EG; Ali SZ
Cancer; 2003 Aug; 99(4):240-6. PubMed ID: 12925986
[TBL] [Abstract][Full Text] [Related]
33. A subset of small cell lung cancer with low neuroendocrine expression and good prognosis: a comparison study of surgical and inoperable cases with biopsy.
Hamanaka W; Motoi N; Ishikawa S; Ushijima M; Inamura K; Hatano S; Uehara H; Okumura S; Nakagawa K; Nishio M; Horai T; Aburatani H; Matsuura M; Iwasaki A; Ishikawa Y
Hum Pathol; 2014 May; 45(5):1045-56. PubMed ID: 24746210
[TBL] [Abstract][Full Text] [Related]
34. Multiple neuroendocrine tumors of the pancreas in von Hippel-Lindau disease patients: histopathological and molecular genetic analysis.
Lubensky IA; Pack S; Ault D; Vortmeyer AO; Libutti SK; Choyke PL; Walther MM; Linehan WM; Zhuang Z
Am J Pathol; 1998 Jul; 153(1):223-31. PubMed ID: 9665483
[TBL] [Abstract][Full Text] [Related]
35. Three cases of concomitant intraductal papillary mucinous neoplasm and pancreatic neuroendocrine tumour.
Tewari N; Zaitoun AM; Lindsay D; Abbas A; Ilyas M; Lobo DN
JOP; 2013 Jul; 14(4):423-7. PubMed ID: 23846940
[TBL] [Abstract][Full Text] [Related]
36. Diffuse pancreatic serous cystadenoma associated with neuroendocrine carcinoma: a case report and review of literature.
Agarwal N; Kumar S; Dass J; Arora VK; Rathi V
JOP; 2009 Jan; 10(1):55-8. PubMed ID: 19129617
[TBL] [Abstract][Full Text] [Related]
37. [Significance of P504s in distinction between solid pseudopapillary tumor of pancreas and pancreatic neuroendocrine tumors].
Chen Z; Shi H; Ying L; Zhai X; Fu X; Liu Q; Lou S
Zhonghua Bing Li Xue Za Zhi; 2015 May; 44(5):320-2. PubMed ID: 26178213
[TBL] [Abstract][Full Text] [Related]
38. Prognostic significance of the aberrant expression of neuroendocrine markers in melanomas.
Wu Y; Lai Y; Zhang M; Li Z
Diagn Pathol; 2021 Aug; 16(1):78. PubMed ID: 34454530
[TBL] [Abstract][Full Text] [Related]
39. Surgical treatment of incidentally identified pancreatic masses.
Fitzgerald TL; Smith AJ; Ryan M; Atri M; Wright FC; Law CH; Hanna SS
Can J Surg; 2003 Dec; 46(6):413-8. PubMed ID: 14680347
[TBL] [Abstract][Full Text] [Related]
40. Molecular alterations in sporadic pancreatic neuroendocrine microadenomas.
Hadano A; Hirabayashi K; Yamada M; Kawanishi A; Takanashi Y; Kawaguchi Y; Nakagohri T; Nakamura N; Mine T
Pancreatology; 2016; 16(3):411-5. PubMed ID: 26905832
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
